Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma

Clinical Cancer Research

Volumn 4, Issue 9, 1998, Pages 2273-2277

  Oda, Yoshinao ^a   Sakamoto, Akio ^a   Shinohara, Norio ^b   Ohga, Takefumi ^a   Uchiumi, Takeshi ^a   Kohno, Kimitoshi ^c   Tsuneyoshi, Masazumi ^a   Kuwano, Michihiko ^a   Iwamoto, Yukihide ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GLYCOPROTEIN P;

ARTICLE; BIOPSY; CANCER GRADING; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIDRUG RESISTANCE; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 0031670312     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gottesman, M. M., and Pastan, I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427, 1993.
2. Alvarez, M., Paull, K., Monks, A., Hose, C., Lee, J-S., Weinstein, J., Grever, M., Bates, S., and Fojo, T. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute anticancer drug screen. J. Clin. Invest., 95: 2205-2214, 1996.
3. Beck, W. T., Grogan, T. M., Willman, C. L., Cordon-Cardo, C., Parham, D. M., Boyett, J. F., Andreeff, M., Bates, S. E., Berard, C. W., Boyett, J. M., Brophy, N. A., Broxterman, H. J., Chan, H. S., Dalton, W. S., Dietel, M., Fojo, A. T., Gascoyne, R. D., Head, D., Houghton, P. J., Srivastava, D. K., Lehnert, M., Leith, C. P., Paietta, E., Pavelic, Z. P., and Weinstein, R. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res., 56: 3010-3020, 1996.
4. Uchiumi, T., Kohno, K., Tanimura, H., Matsuo, K., Sato, S., Uchida, Y., and Kuwano, M. Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differ., 4: 147-157, 1993.
5. Goldsmith, M. E., Madden, M. J., Morrow, C. S., and Cowan, K. H. A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdrl) gene. J. Biol. Chem., 268: 5856-5860, 1993.
6. Chaudhary, P. M., and Roninson, I. B. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst. (Bethesda), 85: 632-639, 1993.
7. Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S. L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., Lieber, M., Cossman, J., Gottesman, M. M., and Pastan, I. Expression of a multi-drug resistance gene in human cancers. J. Natl. Cancer Inst. (Bethesda), 81: 116-124, 1989.
8. Nakagawa, M., Emoto, A., Nasu, N., Hanada, T., Kuwano, M., Cole, S. P. C., and Nomura, Y. Clinical significance of multi-drug resistance associated protein and P-glycoprotein in patients with bladder cancer. J. Urol., 157: 1260-1265, 1997.
9. Ohga T., Koike K., Ono, M., Makino, Y., Itagaki, Y., Tanimoto, M., Kuwano, M., and Kohno, K. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C. and ultraviolet light. Cancer Res., 56: 4224-4228, 1996.
10. Goldsmith, M. E., Madden, M. J., Morrow, C. S., and Cowan, K. H. A Y-box consensus sequence is required for basal expression of the human multidrug resistance (MDR1) gene. J. Biol. Chem., 268: 5856-5860, 1993.
11. Woffe, A. P., Tafuri, S., Ranjan, M., and Familari, M. The Y-box factors: a family of nucleic acid binding proteins conserved from Escherichia coli to man. New Biol., 4: 290-298, 1992.
12. Ladomery, M., and Sommerville, J. A role for Y-box proteins in cell proliferation. BioEssays, 17: 9-11, 1995.
13. Koike, K., Uchiumi, T., Ohga, T., Toh, S., Wada, M., Kohno, K., and Kuwano, M. Nuclear translocation of the Y-box binding protein by ultraviolet light irradiation. FEBS Lett., 477: 390-394, 1997.
14. Ohga, T., Uchiumi, T., Makino, Y., Koike, K., Wada, M., Kuwano, M., and Kohno, K. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J. Biol. Chem., 275: 5597-6000, 1998.
15. Bargou R. C., Jürchott, K., Wagener, C., Bergmann, S., Metzner, S., Bommert, K., Mapara, M. Y., Winzer, K-J., Dietel, M., Dörken, B., and Royer, H-D. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat. Med., 3: 447-450, 1997.
16. Chan, H. S. L., Thorner, P. S., Haddad, G., and Ling, V. Outcome of therapy in osteosarcoma correlates with P-glycoprotein expression. Proc. Am. Assoc. Cancer Res., 32: 366, 1991.
17. Wunder, J. S., Bell, R. S., Wold, L., and Andrulis, I. L. Expression of the multidrug resistance gene in osteosarcoma: a pilot study. J. Orthop. Res., 11: 396-403, 1993.
18. Baldini, N., Scotlandi, K., Barbanti-Brodano, G., Manara, M. C., Maurici, D., Bacci, G., Bertoni, F., Picci, P., Sottili, S., Campanacci, M., and Serra, M. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N. Engl. J. Med., 333: 1380-1385, 1995.
19. Radig, K., Häckel, C., Herting, J., Oda, Y., Mittler, U., Neumann, W., and Roessner, A. Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype. Gen. Diag. Pathol., 142: 139-145, 1997.
20. Sim, F. H., Unni, K. K., Beabout, J. W., and Dahlin, D. C. Osteosarcoma with small cells simulating Ewing's sarcoma. J. Bone Joint Surg. [Am.], 61: 207-215, 1979.
21. Bathhurst, N., Sanerkin, N., and Watt, I. Osteoclast-rich osteosarcoma. Br. J. Radiol., 59: 667-673, 1986.
22. Dahlin, D. C., and Unni, K. K. Osteosarcoma of bone and its important recognizable varieties. Am. J. Surg. Pathol., 1: 61-72, 1977.
23. Naka, T., Fukuda, T., Chuman, H., Iwamoto, Y., Sugioka, Y., Fukui, M., and Tsuneyoshi, M. Proliferative activities in conventional chordoma: a clinicopathologic, DNA flow cytometric, and immunohistochemical analysis of 17 specimens with special reference to anaplastic chordoma showing a diffuse proliferation and nuclear atypia. Hum. Pathol., 27: 381-388, 1996.
24. Kohno, K., Tanimura, H., Sato, S., Nakayama, Y., Makino, Y., Wada, M., Fojo, A. T., and Kuwano, M. Cellular control of human multidrug resistance 1 (mdr-1) gene expression in absence and presence of gene amplification in human cancer cells. J. Biol. Chem., 269: 20503-20508, 1994.
25. Asakuno, K., Kohno, K., Uchiumi, T., Kubo, T., Sato, S., Isono, M., and Kuwano, M. Involvement of a DNA binding protein, MDR-NFl/ YB-1, in human MDR1 gene expression by actinomycin D. Biochem. Biophys. Res. Commun., 199: 1428-1435, 1994.
26. Delling, G., Zach, W., and Alm, J. Quantitative grundsubstanzbestimmung in osteosarkomen und ihre bedeutung für das ansprechen auf eine polychemotherapie. Verh. Dtsch. Ges. Pathol., 69: 605, 1985.
27. Toffoli, G., Frustaci, S., Tumiotto, L., Talamini, R., Gherlinzoni, F., Picci, P., and Boiocchi, M. Expression of MDR1 and GST pai in human soft tissue sarcomas: relation to drug resistance and biologic aggressiveness. Ann. Oncol., 3: 63-69, 1992.
28. Bradley, G., and Ling, V. P-glycoprotein, multidrug resistance and tumor progression. Cancer Metastasis Rev., 13: 223-233, 1994.
29. Pinedo, H. M., and Giaccone, G. P-glycoprotein: a marker of cancer-cell behavior. N. Engl. J. Med., 333: 1417-1419, 1995.
30. Weinstein, R. S., Jakate S. M., Dominguez, J. M., Lebovitz, M. D., Koukoulis, G. K., Kuszak, J. R., Klusens, L. F., Grogan, T. M., Saclarides, T. J., Roninson, I. B., and Coon, J. S. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res., 51: 2720-2726, 1991.